Product: MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SYR C-IV, 55 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-55
Reason for recall: Lack of Assurance of Sterility
Recall initiated: 20190619
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated